Home › Companies › Vertex Pharmaceuticals Incorporated › 2025-2026
Compiled from SEC Form N-PX filings and Vertex Pharmaceuticals Incorporated’s Form 8-K (Item 5.07 on EDGAR). Page generated 04 October 2026.
Explore Vertex Pharmaceuticals Incorporated in the interactive database Compare manager voting policies
These tallies are Vertex Pharmaceuticals Incorporated’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Sangeeta Bhatia | 221,280,173 | 1,624,141 | 93,322 | -- | 10,337,217 | Majority: yes |
| Elect Director: Lloyd Carney | 213,048,550 | 9,855,369 | 93,717 | -- | 10,337,217 | Majority: yes |
| Elect Director: Alan Garber | 219,396,452 | 3,506,604 | 94,580 | -- | 10,337,217 | Majority: yes |
| Elect Director: Reshma Kewalramani | 221,911,160 | 999,306 | 87,170 | -- | 10,337,217 | Majority: yes |
| Elect Director: Michel Lagarde | 220,336,343 | 2,566,485 | 94,808 | -- | 10,337,217 | Majority: yes |
| Elect Director: Jeffrey Leiden | 220,333,763 | 2,576,638 | 87,235 | -- | 10,337,217 | Majority: yes |
| Elect Director: Diana McKenzie | 221,316,590 | 1,590,047 | 90,999 | -- | 10,337,217 | Majority: yes |
| Elect Director: Bruce Sachs | 209,717,815 | 13,186,265 | 93,556 | -- | 10,337,217 | Majority: yes |
| Elect Director: Jennifer Schneider | 221,301,670 | 1,602,686 | 93,280 | -- | 10,337,217 | Majority: yes |
| Elect Director: Nancy Thornberry | 220,320,992 | 2,583,895 | 92,749 | -- | 10,337,217 | Majority: yes |
| Proposal 2: Based upon the following votes, the shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026: | 223,514,070 | 9,597,395 | 223,388 | -- | 0 | Majority: yes |
| Proposal 3: Based upon the following votes, the shareholders approved, on an advisory basis, the 2025 compensation program for the Company's named executive officers: | 207,918,843 | 14,522,776 | 556,017 | -- | 10,337,217 | Majority: yes |
| Proposal 4: Based upon the following votes, the shareholders approved the Company's 2026 Stock and Option Plan. | 216,097,268 | 6,523,460 | 376,908 | -- | 10,337,217 | Majority: yes |
| Proposal 5: Based upon the following votes, the shareholders approved a shareholder proposal regarding shareholder right to act by written consent: | 126,892,696 | 95,756,148 | 348,792 | -- | 10,337,217 | Majority: yes |
Source: Vertex Pharmaceuticals Incorporated, Form 8-K — read the filing on EDGAR.
Each item below shows how the 1,197 asset managers that disclosed a Vertex Pharmaceuticals Incorporated vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Vertex Pharmaceuticals Incorporated’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2026-05-13.
Combines 22 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on an advisory basis, the 2025 compensation program for the Company's named executive officers:”): 207,918,843 for, 14,522,776 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 254,163,953 outstanding shares: 82% for, 6% against (88% of the company cast a for/against vote).
The 1,176 asset managers below cast 96% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 66,967,020 | 0 | 0 | 0 | For |
| Vanguard | 26,459,860 | 62 | 2 | 0 | For |
| BlackRock | 21,108,785 | 1,105 | 81 | 0 | For |
| Capital Research Global Investors | 21,018,928 | 0 | 0 | 0 | For |
| Invesco | 15,710,190 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 10,821,600 | 0 | 0 | 0 | For |
| Fidelity | 7,816,684 | 0 | 0 | 0 | For |
| State Street | 7,470,671 | 75,297 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 6,117,725 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| Loomis Sayles | 4,471,906 | 134,712 | 0 | 0 | For |
| Janus Henderson | 4,263,790 | 8,750 | 0 | 0 | For |
| Charles Schwab | 3,786,813 | 0 | 0 | 0 | For |
| AllianceBernstein | 3,517,899 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,175,605 | 38,465 | 0 | 0 | For |
| JPMorgan | 3,128,963 | 0 | 0 | 0 | For |
| Wellington | 3,038,819 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 2,696,307 | 3,063 | 0 | 0 | For |
| Clearbridge Investments, LLC | 2,657,135 | 620 | 0 | 0 | For |
| Northern Trust | 2,316,694 | 22,756 | 0 | 0 | For |
| Victory Capital | 2,277,576 | 757 | 0 | 0 | For |
| UBS | 0 | 1,928,382 | 0 | 0 | Against |
| Winslow Capital Management, LLC | 1,835,898 | 0 | 0 | 0 | For |
| Amundi | 0 | 1,805,464 | 0 | 0 | Against |
Showing the 25 largest of 1,176 asset managers. See all 1,176 in the interactive database.
Meeting held 2026-05-13.
Combines 8 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Proposal 4: Based upon the following votes, the shareholders approved the Company's 2026 Stock and Option Plan.”): 216,097,268 for, 6,523,460 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 254,163,953 outstanding shares: 85% for, 3% against (88% of the company cast a for/against vote).
The 227 asset managers below cast 99.5% of the shares they voted on this item FOR (123,739,120 for, 521,834 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,346 | 30 | 2 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,716 | 0 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 275,000 | 351,607 | 0 | 0 | Against |
| Prudential/PGIM | 503,879 | 53,979 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 227 asset managers. See all 227 in the interactive database.
Meeting held 2026-05-13.
Combines 8 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Proposal 2: Based upon the following votes, the shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026:”): 223,514,070 for, 9,597,395 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 254,163,953 outstanding shares: 88% for, 4% against (92% of the company cast a for/against vote).
The 209 asset managers below cast 99.9% of the shares they voted on this item FOR (123,749,416 for, 120,672 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,822,872 | 20,504 | 0 | 0 | For |
| BlackRock | 9,502,594 | 1,460 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,672 | 44 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,205 | 197 | 0 | 0 | For |
Showing the 25 largest of 209 asset managers. See all 209 in the interactive database.
Meeting held 2026-05-13.
Combines 6 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Sangeeta Bhatia”): 221,280,173 for, 1,624,141 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 254,163,953 outstanding shares: 87% for, 0.7% against (88% of the company cast a for/against vote).
The 205 asset managers below cast 99.8% of the shares they voted on this item FOR (123,691,458 for, 160,009 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,368 | 9 | 0 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,716 | 0 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Meeting held 2026-05-13.
Combines 6 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Lloyd Carney”): 213,048,550 for, 9,855,369 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 254,163,953 outstanding shares: 84% for, 4% against (88% of the company cast a for/against vote).
The 205 asset managers below cast 99.4% of the shares they voted on this item FOR (123,163,273 for, 688,193 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,822,871 | 20,505 | 0 | 0 | For |
| BlackRock | 9,501,262 | 2,792 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,716 | 0 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,217 | 550 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,205 | 197 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Meeting held 2026-05-13.
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Alan Garber”): 219,396,452 for, 3,506,604 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 254,163,953 outstanding shares: 86% for, 1% against (88% of the company cast a for/against vote).
The 205 asset managers below cast 99.8% of the shares they voted on this item FOR (123,660,539 for, 190,928 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,359 | 18 | 0 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,716 | 0 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Meeting held 2026-05-13.
Combines 5 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Reshma Kewalramani”): 221,911,160 for, 999,306 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 254,163,953 outstanding shares: 87% for, 0.4% against (88% of the company cast a for/against vote).
The 205 asset managers below cast 99.9% of the shares they voted on this item FOR (123,844,869 for, 6,597 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,372 | 4 | 0 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,716 | 0 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Meeting held 2026-05-13.
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Michel Lagarde”): 220,336,343 for, 2,566,485 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 254,163,953 outstanding shares: 87% for, 1% against (88% of the company cast a for/against vote).
The 205 asset managers below cast 99.9% of the shares they voted on this item FOR (123,844,860 for, 6,607 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,363 | 14 | 0 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,716 | 0 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Meeting held 2026-05-13.
Combines 6 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Jeffrey Leiden”): 220,333,763 for, 2,576,638 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 254,163,953 outstanding shares: 87% for, 1% against (88% of the company cast a for/against vote).
The 205 asset managers below cast 99.8% of the shares they voted on this item FOR (123,665,885 for, 185,582 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,364 | 13 | 0 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,693 | 23 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Meeting held 2026-05-13.
Combines 6 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Diana McKenzie”): 221,316,590 for, 1,590,047 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 254,163,953 outstanding shares: 87% for, 0.7% against (88% of the company cast a for/against vote).
The 205 asset managers below cast 99.9% of the shares they voted on this item FOR (123,839,900 for, 11,567 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,372 | 5 | 0 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,716 | 0 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Meeting held 2026-05-13.
Combines 6 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Bruce Sachs”): 209,717,815 for, 13,186,265 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 254,163,953 outstanding shares: 83% for, 5% against (88% of the company cast a for/against vote).
The 205 asset managers below cast 99.6% of the shares they voted on this item FOR (123,454,929 for, 396,538 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,315 | 62 | 0 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,672 | 44 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Meeting held 2026-05-13.
Combines 5 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Jennifer Schneider”): 221,301,670 for, 1,602,686 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 254,163,953 outstanding shares: 87% for, 0.7% against (88% of the company cast a for/against vote).
The 205 asset managers below cast 99.9% of the shares they voted on this item FOR (123,831,107 for, 20,360 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,372 | 5 | 0 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,716 | 0 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Meeting held 2026-05-13.
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Nancy Thornberry”): 220,320,992 for, 2,583,895 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 254,163,953 outstanding shares: 87% for, 1% against (88% of the company cast a for/against vote).
The 205 asset managers below cast 99.9% of the shares they voted on this item FOR (123,839,891 for, 11,576 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 23,843,363 | 14 | 0 | 0 | For |
| BlackRock | 9,504,054 | 0 | 0 | 0 | For |
| Invesco | 7,233,083 | 0 | 0 | 0 | For |
| Fidelity | 6,487,476 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 3,068,716 | 0 | 0 | 0 | For |
| JPMorgan | 3,042,993 | 0 | 0 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,084,687 | 0 | 0 | 0 | For |
| TIAA | 1,072,556 | 0 | 0 | 0 | For |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 1,023,358 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 993,571 | 0 | 0 | 0 | For |
| T. Rowe Price | 974,667 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 626,607 | 0 | 0 | 0 | For |
| Prudential/PGIM | 557,858 | 0 | 0 | 0 | For |
| Dimensional | 495,835 | 0 | 0 | 0 | For |
| Jackson National | 495,416 | 0 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 205 asset managers. See all 205 in the interactive database.
Meeting held 2026-05-13.
Combines 7 wordings of this item as funds reported it.
57% Majority: yes · of votes cast
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Proposal 5: Based upon the following votes, the shareholders approved a shareholder proposal regarding shareholder right to act by written consent:”): 126,892,696 for, 95,756,148 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 254,163,953 outstanding shares: 49.9% for, 38% against (88% of the company cast a for/against vote).
The 204 asset managers below cast 54.1% of the shares they voted on this item FOR (67,035,997 for, 56,829,234 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 36,479,865 | 0 | 0 | 0 | For |
| Vanguard | 1,862,588 | 21,980,785 | 2 | 0 | Against |
| BlackRock | 13,537 | 9,490,517 | 0 | 0 | Against |
| Invesco | 6,870,069 | 363,014 | 0 | 0 | For |
| Fidelity | 71,363 | 6,416,113 | 0 | 0 | Against |
| INVESTMENT CO OF AMERICA | 6,269,142 | 0 | 0 | 0 | For |
| AMCAP FUND | 4,621,267 | 0 | 0 | 0 | For |
| State Street | 6,732 | 3,061,984 | 0 | 0 | Against |
| JPMorgan | 0 | 3,042,993 | 0 | 0 | Against |
| Charles Schwab | 550 | 1,860,217 | 0 | 0 | Against |
| Columbia Threadneedle | 1,386,789 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,320,751 | 0 | 0 | 0 | For |
| Loomis Sayles | 0 | 1,084,687 | 0 | 0 | Against |
| TIAA | 0 | 1,072,556 | 0 | 0 | Against |
| Legg Mason | 1,030,852 | 0 | 0 | 0 | For |
| Victory Capital | 944,964 | 78,394 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,743 | 991,828 | 0 | 0 | Against |
| T. Rowe Price | 0 | 974,667 | 0 | 0 | Against |
| HARBOR FUNDS | 0 | 688,124 | 0 | 0 | Against |
| AB LARGE CAP GROWTH FUND INC | 645,094 | 0 | 0 | 0 | For |
| American Century | 275,000 | 351,607 | 0 | 0 | Against |
| Prudential/PGIM | 38,020 | 519,838 | 0 | 0 | Against |
| Dimensional | 0 | 495,835 | 0 | 0 | Against |
| Jackson National | 401,065 | 94,351 | 0 | 0 | For |
| Hartford | 463,402 | 0 | 0 | 0 | For |
Showing the 25 largest of 204 asset managers. See all 204 in the interactive database.
Meeting held 2026-05-13.
Combines 4 wordings of this item as funds reported it.
99.9% fund support · no official result
The 104 asset managers below cast 99.9% of the shares they voted on this item FOR (7,945,219 for, 6,595 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 11,506 | 0 | 9,492,548 | 0 | Abstain |
| Vanguard | 2,219,290 | 2 | 1,011 | 0 | For |
| Charles Schwab | 1,860,767 | 0 | 0 | 0 | For |
| Loomis Sayles | 0 | 0 | 1,084,687 | 0 | Abstain |
| HARBOR FUNDS | 688,124 | 0 | 0 | 0 | For |
| Prudential/PGIM | 517,196 | 0 | 0 | 0 | For |
| Jackson National | 25,290 | 0 | 470,126 | 0 | Abstain |
| Hartford | 463,402 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 391,443 | 0 | Abstain |
| ADVISORS' INNER CIRCLE FUND | 384,411 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 138,951 | 0 | 153,563 | 0 | Abstain |
| Transamerica | 217,773 | 0 | 0 | 0 | For |
| Six Circles Trust | 0 | 0 | 196,313 | 0 | Abstain |
| NEOS ETF Trust | 167,874 | 0 | 0 | 0 | For |
| Global X | 137,782 | 0 | 0 | 0 | For |
| Russell Investments | 109,721 | 0 | 0 | 0 | For |
| Brighthouse | 87,956 | 0 | 19,989 | 0 | For |
| John Hancock | 0 | 0 | 107,309 | 0 | Abstain |
| Calamos | 99,947 | 0 | 0 | 0 | For |
| Cardano Risk Management B.V. | 84,422 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 75,360 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 71,440 | 0 | 0 | 0 | For |
| Natixis | 0 | 0 | 71,244 | 0 | Abstain |
| Gateway Trust | 0 | 0 | 64,879 | 0 | Abstain |
| SEI | 58,186 | 0 | 0 | 0 | For |
Showing the 25 largest of 104 asset managers. See all 104 in the interactive database.
Meeting held 2026-05-13.
100% fund support · no official result
The 17 asset managers below cast 100% of the shares they voted on this item FOR (113 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Brighthouse | 0 | 0 | 0 | 0 | Not Voted |
| Lincoln Financial | 0 | 0 | 0 | 0 | Not Voted |
| Empower | 0 | 0 | 0 | 0 | N/A |
| Venerable Variable Insurance Trust | 0 | 0 | 0 | 0 | Unknown |
| Morningstar Funds Trust | 0 | 0 | 15,070 | 0 | Abstain |
| MUTUAL FUND SERIES TRUST | 107 | 0 | 0 | 0 | Unknown |
| SA FUNDS INVESTMENT TRUST | 0 | 0 | 0 | 0 | Unknown |
| Advisors' Inner Circle Fund III | 0 | 0 | 4,346 | 0 | Abstain |
| RBB Fund Trust | 0 | 0 | 0 | 0 | Unknown |
| HC CAPITAL TRUST | 0 | 0 | 0 | 0 | Unknown |
| Symmetry Panoramic Trust | 0 | 0 | 854 | 0 | Abstain |
| SARATOGA ADVANTAGE TRUST | 0 | 0 | 0 | 0 | Not Voted |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 0 | Non-Voting Ballot |
| Multi-Select Securities Fund for Puerto Rico Residents | 0 | 0 | 0 | 0 | Not Voted |
| Institutional Investment Strategy Fund | 0 | 0 | 0 | 0 | Unknown |
| Keel Point, LLC | 6 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 0 | 0 | 0 | 0 | Unknown |
Meeting held 2026-05-13.
Combines 2 wordings of this item as funds reported it.
0.9% fund support · no official result
The 6 asset managers below cast 0.9% of the shares they voted on this item FOR (47 for, 5,822 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| NORTHERN LIGHTS FUND TRUST II | 0 | 3,428 | 0 | 0 | Against |
| TEALWOOD ASSET MANAGEMENT INC | 0 | 2,184 | 0 | 0 | Against |
| WILLIAMSBURG INVESTMENT TRUST | 0 | 0 | 0 | 0 | Not Voted |
| McGowan Group Asset Management, Inc. | 0 | 160 | 0 | 0 | Against |
| HARBOUR INVESTMENT MANAGEMENT LLC | 0 | 50 | 0 | 0 | Against |
| Two Roads Shared Trust | 47 | 0 | 0 | 0 | For |
Meeting held 2025-05-14 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on an advisory basis, the 2024 compensation program for the Company's named executive officers:”): 208,886,386 for, 17,048,300 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 254,163,953 outstanding shares: 82% for, 7% against (89% of the company cast a for/against vote).
The 6 asset managers below cast 24% of the shares they voted on this item FOR (21,236 for, 68,666 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| OSSIAM | 0 | 68,666 | 0 | 0 | Against |
| Investment Management Corp of Ontario | 11,574 | 0 | 0 | 0 | For |
| Slow Capital, Inc. | 6,423 | 0 | 0 | 0 | For |
| Philip James Wealth Mangement, LLC | 2,926 | 0 | 0 | 0 | For |
| NORRIS PERNE & FRENCH LLP/MI | 305 | 0 | 0 | 0 | For |
| OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC | 8 | 0 | 0 | 0 | For |
Meeting held 2026-05-13.
All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.
100% fund support · no official result
The 5 asset managers below cast 100% of the shares they voted on this item FOR.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| NORTHERN LIGHTS FUND TRUST II | 3,428 | 0 | 0 | 0 | For |
| TEALWOOD ASSET MANAGEMENT INC | 2,184 | 0 | 0 | 0 | For |
| WILLIAMSBURG INVESTMENT TRUST | 1,000 | 0 | 0 | 0 | For |
| HARBOUR INVESTMENT MANAGEMENT LLC | 550 | 0 | 0 | 0 | For |
| McGowan Group Asset Management, Inc. | 160 | 0 | 0 | 0 | For |
Reported under meeting date 2026-03-16; no official results on file for that date.
100% fund support · no official result
The 4 asset managers below cast 100% of the shares they voted on this item FOR (120,346 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | 118,936 | 0 | 0 | 0 | For |
| Spinnaker ETF Series | 1,149 | 0 | 0 | 0 | For |
| GLOBALT Investments LLC / GA | 255 | 0 | 0 | 0 | For |
| Robertson Stephens Wealth Management, LLC | 6 | 0 | 0 | 0 | For |
Meeting held 2026-05-13.
93% Majority: yes · of votes cast
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on an advisory basis, the 2025 compensation program for the Company's named executive officers:”): 207,918,843 for, 14,522,776 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 254,163,953 outstanding shares: 82% for, 6% against (88% of the company cast a for/against vote).
The 4 asset managers below cast 75% of the shares they voted on this item FOR (629 for, 210 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 460 | 0 | 0 | 0 | For |
| Genus Capital Management Inc. | 0 | 210 | 0 | 0 | Against |
| CHELSEA COUNSEL CO | 150 | 0 | 0 | 0 | For |
| Arista Wealth Management, LLC | 19 | 0 | 0 | 0 | For |
Meeting held 2026-05-13.
All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Ultimus Managers Trust | 0 | 0 | 0 | 0 | For All |
| Rockport Wealth LLC | 9 | 0 | 0 | 0 | For |
Meeting held 2026-05-13.
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (120 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Members Trust Co | 73 | 0 | 0 | 0 | For |
| Two Roads Shared Trust | 47 | 0 | 0 | 0 | For |
Meeting held 2026-05-13.
93% Majority: yes · of votes cast
Vertex Pharmaceuticals Incorporated’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on an advisory basis, the 2025 compensation program for the Company's named executive officers:”): 207,918,843 for, 14,522,776 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 254,163,953 outstanding shares: 82% for, 6% against (88% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (120 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Members Trust Co | 73 | 0 | 0 | 0 | For |
| Two Roads Shared Trust | 47 | 0 | 0 | 0 | For |
Ranked by the number of Vertex Pharmaceuticals Incorporated shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 254,163,953 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Capital Group | 26.35% |
| 2 | Vanguard | 10.41% |
| 3 | BlackRock | 8.31% |
| 4 | Capital Research Global Investors | 8.27% |
| 5 | Invesco | 6.18% |
| 6 | PARAMETRIC PORTFOLIO ASSOCIATES LLC | 4.26% |
| 7 | Fidelity | 3.08% |
| 8 | State Street | 2.97% |
| 9 | INVESTMENT CO OF AMERICA | 2.47% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.41% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Capital World Investors | 11.31% | DEF14A |
| BlackRock | 9.43% | 13F |
| The Vanguard Group | 8.77% | DEF14A |
| Capital Research Global Investors. | 6.81% | DEF14A |
| State Street | 4.62% | 13F |
| JPMorgan Chase | 2.77% | 13F |
| Wellington Management | 1.26% | 13F |
| Morgan Stanley | 1.23% | 13F |
| Northern Trust | 1.01% | 13F |
| Invesco | 1.01% | 13F |
Percentages above are of 254,163,953 shares outstanding, as reported by Vertex Pharmaceuticals Incorporated on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Vertex Pharmaceuticals Incorporated’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At Vertex Pharmaceuticals Incorporated's shareholder meeting held 2026-05-13, in the 2025-2026 proxy season, 1,197 asset managers reported how they voted in their SEC Form N-PX filings, covering 17,669 separate fund positions. Their filings are grouped here into 24 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory vote to approve named executive officer compensation. — FOR was 93% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Vertex Pharmaceuticals Incorporated's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).
Vertex Pharmaceuticals Incorporated proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).